Zacks Investment Research·20h ago
Bet On These 5 Top-Ranked Stocks With Increasing P/E RatiosTap these five stocks, W, DHR, ISRG, BEAT and CSW, with rising P/E ratios to try out an out-of-the-box approach.
Danaher Corporation(DHR)Earnings, Financials & Key Ratios
DHR•NYSE
$194.19
38.5× P/E·Price updated Jul 7, 2026
SectorHealthcareIndustryDiagnostics & ResearchSub-IndustryLife Science Instruments and Sequencing Tools
AboutDanaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.Show more
- Revenue$24.57B+2.9%
- EBITDA$7.58B+0.6%
- Net Income$3.61B-7.3%
- EPS (Diluted)5.04-4.7%
- Gross Margin60.93%+2.4%
- EBITDA Margin30.87%-2.2%
- Operating Margin20.91%-3.7%
- Net Margin14.71%-9.9%
- ROE7.08%-6.4%
DHR Price & Volume
Danaher Corporation (DHR) stock price & volume — 10-year historical chart
Loading chart...
Resilient Margins Navigate Bioprocessing Demand Normalization Headwinds
Investment Thesis • Updated 2026Q1
VerdictNeutral
Growth:Mixed
Profitability:Moderate
Financial:Healthy
Cash Flow:Robust
Primary Risk:Bioprocessing demand normalization
Key Thesis Takeaways
- Danaher remains a high-quality compounder, though it faces a complex transition as it navigates post-pandemic bioprocessing demand normalization.
- While the company maintains a robust 60.3% gross margin as of 2026Q1, investors should monitor the $42.8 billion goodwill balance, which represents over 50% of total assets and poses potential impairment risks.
- Future growth hinges on the company's ability to leverage its diagnostic and life sciences portfolio to offset inconsistent revenue growth, which fluctuated between a 1.9% decline and a 4.6% increase over the last ten quarters.
Verdict Logic
while the company demonstrates strong cash conversion with an OCF/NI ratio of 1.28 in 2026Q1, the current P/E of 38.82 suggests the market is pricing in significant growth that may be challenged by ongoing bioprocessing sector normalization.
DHR Growth Metrics
Danaher Corporation (DHR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years5.46%
5 Years1.97%
3 Years-2.67%
TTM4.02%
Profit CAGR
10 Years3.36%
5 Years-0.18%
3 Years-20.56%
TTM-2.02%
EPS CAGR
10 Years0.62%
5 Years0.61%
3 Years-19.44%
TTM0.39%
Return on Capital
10 Years7.82%
5 Years8.43%
3 Years6.99%
Last Year6.97%
DHR Recent Earnings
Danaher Corporation (DHR) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 11/12 qtrs (92%)●Beat Revenue 10/12 qtrs (83%)
Q2 2026Latest
Apr 21, 2026Metric
Actual
Est
EPS
$2.06+6.2%
$1.94
Rev
$6.0B-0.5%
$6.0B
Q1 2026
Jan 28, 2026Metric
Actual
Est
EPS
$2.23+3.2%
$2.16
Rev
$6.8B+0.4%
$6.8B
Q4 2025
Oct 21, 2025Metric
Actual
Est
EPS
$1.89+9.9%
$1.72
Rev
$6.1B+0.9%
$6.0B
Q3 2025
Jul 22, 2025Metric
Actual
Est
EPS
$1.80+9.8%
$1.64
Rev
$5.9B+1.7%
$5.8B
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Apr 21, 2026 | $2.06vs $1.94+6.2% | $6.0Bvs $6.0B-0.5% |
| Q1 2026 | Jan 28, 2026 | $2.23vs $2.16+3.2% | $6.8Bvs $6.8B+0.4% |
| Q4 2025 | Oct 21, 2025 | $1.89vs $1.72+9.9% | $6.1Bvs $6.0B+0.9% |
| Q3 2025 | Jul 22, 2025 | $1.80vs $1.64+9.8% | $5.9Bvs $5.8B+1.7% |
Based on last 12 quarters of dataView full earnings history →
Latest DHR News
Recent stock market news and headlines for Danaher Corporation (DHR)
PRNewsWire·4 days ago
Did Danaher Corporation Insiders Breach their Fiduciary Duties to Shareholders?Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
PRNewsWire·Jun 29, 2026
Danaher Foundation Commits $1 Million to Ebola Outbreak Relief Efforts in Central AfricaWASHINGTON, June 29, 2026 /PRNewswire/ -- The Danaher Foundation, supported by Danaher Corporation (NYSE: DHR), today announced a $1 million commitment to support urgent, on-the-ground response to the Ebola Bundibugyo outbreak in the Democratic Republic of Congo (DRC) and Uganda through Save the Children, the International Rescue Committee (IRC) and the World Food Program USA in support of the World Food Programme (WFP). The funding will be distributed across the three organizations to enable rapid, flexible response to evolving conditions on the ground.
Zacks Investment Research·Jun 25, 2026
Danaher (DHR) Crossed Above the 20-Day Moving Average: What That Means for InvestorsDanaher (DHR) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, DHR crossed above the 20-day moving average, suggesting a short-term bullish trend.
The Motley Fool·Jun 24, 2026
Danaher Is Down 22% This Year. Is the Masimo Acquisition the Entry Point Investors Have Been Waiting for?The company is seeing a big uptick in equipment orders. Danaher said it expects its acquisition of Masimo to be accretive to earnings this year.
Peers Comparison
Key metrics vs top competitors for Danaher Corporation (DHR)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $194.19 | $137.44B | 38.53 | 2.9% | 14.71% | 7.08% | 0.64% | |
| $516.62 | $191.99B | 29.12 | 3.91% | 15.18% | 13.23% | — | |
| $131.14 | $37.04B | 28.70 | 6.73% | 19.55% | 20.84% | — | |
| $374.93 | $24.44B | 34.84 | 6.99% | 11.91% | 8.04% | — | |
| $292.50 | $7.9B | 10.50 | 0.65% | 6.52% | 2.4% | — | |
| $58.25 | $8.87B | -388.33 | 2.08% | -0.34% | -0.5% | — |
Compare DHR vs Peers
Danaher Corporation (DHR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
DHR SEC Filings & Documents
Danaher Corporation (DHR) SEC filings — annual & quarterly reports (10-K, 10-Q)
8-K Announcements
6Material company update
Jun 3, 2026·SEC
Material company update
May 7, 2026·SEC
Material company update
Apr 29, 2026·SEC
10-K Annual Reports
210-Q Quarterly Reports
5Get notified when DHR posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
DHR Frequently Asked Questions
Danaher Corporation (DHR) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Danaher Corporation's revenue?
Danaher Corporation (DHR) reported $24.78B in revenue for fiscal year 2025. This represents a 1268% increase from $1.81B in 1996.
How fast is Danaher Corporation growing?
Danaher Corporation (DHR) grew revenue by 2.9% over the past year. Growth has been modest.
Is DHR profitable?
Yes, Danaher Corporation (DHR) is profitable, generating $3.69B in net income for fiscal year 2025 (14.7% net margin).
Dividend & Returns
Does DHR pay dividends?
Yes, Danaher Corporation (DHR) pays a dividend with a yield of 0.64%. This makes it attractive for income-focused investors.
What is DHR's return on equity?
Danaher Corporation (DHR) has a return on equity (ROE) of 7.1%. This is below average, suggesting room for improvement.
What is Danaher Corporation's free cash flow?
Danaher Corporation (DHR) generated $5.29B in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.